United Kingdom · Royal Society of Chemistry

workspace_premium Q1 — Biochemistry lock_open Open Access

MedChemComm

MedChemComm is a journal indexed in SJR in Biochemistry and Drug Discovery with an H index of 49. It has a best quartile of Q1.

MedChemComm focuses its scope in these topics and keywords: activity, biological, inhibitor, derivatives, drug, discovery, chemistry, approved, inhibitors, characterization, ...

ISSN: 2040-2503

Publisher: Royal Society of Chemistry

Category: Biochemistry

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

NPD Q1

H-index 49

Acceptance rate pie_chart

31%

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

NPD Open Access

Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

SJR Impact

—

H-index

Docs (year)

194

Docs 3y

707

Total refs

10426

Cites 3y

1875

Citable 3y

668

Cites/Doc 2y

283

Ref/Doc

5374.0

Immediate OA

—

Embargoed OA

0 €

Non OA / Submission

—

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Carbohydrates themed issue

When proteins start to make sense: fine-tuning of aminoglycosides for PTC suppression therapy

Design, synthesis and biological evaluation of beta-peptoid-capped HDAC inhibitors with anti-neuroblastoma and anti-glioblastoma activity

Design, synthesis and bioevaluation of tacrine hybrids with cinnamate and cinnamylidene acetate derivatives as potential anti-Alzheimer drugs

Design, synthesis and anti-proliferative activities of novel 7'-O-substituted schisantherin A derivatives

Design of glycosyltransferase inhibitors targeting human O-GlcNAc transferase (OGT)

Design and synthesis of thiamine analogues to study their binding to the ECF transporter for thiamine in bacteria

Design and synthesis of membrane-targeting antibiotics: from peptides- to aminosugar-based antimicrobial cationic amphiphiles

Design and synthesis of fused soluble epoxide hydrolase/peroxisome proliferator-activated receptor modulators

Dehydroabietylamine derivatives as multifunctional agents for the treatment of Alzheimer's disease

Concise synthesis of spergualin-inspired molecules with broad-spectrum antibiotic activity

Computation of protein-ligand binding free energies using quantum mechanical bespoke force fields

SHOW MORE ARTICLES

Chromanones: selective and reversible monoamine oxidase B inhibitors with nanomolar potency

1,2,3-Dithiazoles -new reversible melanin synthesis inhibitors: a chemical genomics study

Branched a-d-mannopyranosides: a new class of potent FimH antagonists

Beyond substrate analogues: new inhibitor chemotypes for glycosyltransferases

Application of QM/MM and QM methods to investigate histone deacetylase 8

Anti-bacterial glycosyl triazoles -identification of an N-acetylglucosamine derivative with bacteriostatic activity against Bacillus

Amyloid beta derived switch-peptides as a tool for investigation of early events of aggregation: a combined experimental and theoretical approach

A step forward in the sigma enigma: a role for chirality in the sigma1 receptor-ligand interaction?

A novel surface-coated nanocarrier for efficient encapsulation and delivery of camptothecin to cells

A mechanistic study on the a-N-acetylgalactosaminidase from E. meningosepticum: a family 109 glycoside hydrolase

A fundamental view of enthalpy-entropy compensation

A cyclosporine derivative is a substrate of the oligopeptide transporter PepT1

FAQs

SJR is not available (NPD) for MedChemComm in the CountryOfPapers database.

Immediate OA APC is not available (NPD).

The acceptance rate recorded for MedChemComm is 31%.

MedChemComm

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of MedChemComm?

What is the APC / publication cost?

What is the acceptance rate?